SULFATINIB
SULFATINIB Uses, Dosage, Side Effects, Food Interaction and all others data.
SULFATINIB is under investigation in clinical trial NCT02588170 (Phase III Study of SULFATINIB in Treating Advanced Extrapancreatic Neuroendocrine Tumors).
| Trade Name | SULFATINIB |
| Generic | Surufatinib |
| Surufatinib Other Names | SULFATINIB, Surufatinib |
| Type | |
| Formula | C24H28N6O3S |
| Weight | Average: 480.59 Monoisotopic: 480.19435996 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here SULFATINIB
